Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older
Purpose: The present study aimed to evaluate the oncologic outcomes of patients 80 years or older compared with younger patients, and we then further investigated the efficacy of chemotherapy in individuals 80 years or older.Methods: A retrospective analysis was conducted using the Surveillance, Epi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2020.525421/full |
id |
doaj-5af2b88f9de04d059100493bfddd882e |
---|---|
record_format |
Article |
spelling |
doaj-5af2b88f9de04d059100493bfddd882e2020-11-25T03:05:58ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-10-01710.3389/fmed.2020.525421525421Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or OlderWenting Liu0Mengyuan Zhang1Jun Wu2Ran Tang3Liqun Hu4Geriatric Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, ChinaGeriatric Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, ChinaGeriatric Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, ChinaDepartment of Pediatric Surgery, Anhui Provincial Children's Hospital, Hefei, ChinaGeriatric Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, ChinaPurpose: The present study aimed to evaluate the oncologic outcomes of patients 80 years or older compared with younger patients, and we then further investigated the efficacy of chemotherapy in individuals 80 years or older.Methods: A retrospective analysis was conducted using the Surveillance, Epidemiology and End Results database. The χ2 test was used to analyze the different clinicopathologic and demographic variables between 65- and 79-year and ≥80-year groups. Kaplan–Meier analysis and log-rank testing were used to compare colorectal cancer (CRC)–specific survival (CCSS) curves between different groups. Multivariate and univariate Cox proportional hazards models with hazard ratios (HRs) and 95% confidence intervals (CIs) were also used to assess CCSS and OS.Results: A total of 189,926 patients were included in our study. Compared with 65- to 79-year-old patients, age 80 years or older was associated with 48.4% increased CRC-specific mortality (HR = 1.484, 95% CI = 1.453–1.516, P < 0.0001; using 65–79 years old as the reference). Moreover, not receiving chemotherapy was significantly associated with an increased risk of CRC-related death, independent of other prognostic factors (HR = 0.615, 95% CI = 0.589–0.643, P < 0.0001) in individuals 80 years or older.Conclusions: This large population-based study showed that older age was associated with worse oncologic outcomes compared to younger age. Chemotherapy could offer survival benefit for very old patients diagnosed with CRC, and we strongly believed that very old patients were undertreated in the present medical practices.https://www.frontiersin.org/articles/10.3389/fmed.2020.525421/fullcolorectal cancerchemotherapy80 yearspopulation-basedsurvival |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wenting Liu Mengyuan Zhang Jun Wu Ran Tang Liqun Hu |
spellingShingle |
Wenting Liu Mengyuan Zhang Jun Wu Ran Tang Liqun Hu Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older Frontiers in Medicine colorectal cancer chemotherapy 80 years population-based survival |
author_facet |
Wenting Liu Mengyuan Zhang Jun Wu Ran Tang Liqun Hu |
author_sort |
Wenting Liu |
title |
Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older |
title_short |
Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older |
title_full |
Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older |
title_fullStr |
Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older |
title_full_unstemmed |
Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older |
title_sort |
oncologic outcome and efficacy of chemotherapy in colorectal cancer patients aged 80 years or older |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2020-10-01 |
description |
Purpose: The present study aimed to evaluate the oncologic outcomes of patients 80 years or older compared with younger patients, and we then further investigated the efficacy of chemotherapy in individuals 80 years or older.Methods: A retrospective analysis was conducted using the Surveillance, Epidemiology and End Results database. The χ2 test was used to analyze the different clinicopathologic and demographic variables between 65- and 79-year and ≥80-year groups. Kaplan–Meier analysis and log-rank testing were used to compare colorectal cancer (CRC)–specific survival (CCSS) curves between different groups. Multivariate and univariate Cox proportional hazards models with hazard ratios (HRs) and 95% confidence intervals (CIs) were also used to assess CCSS and OS.Results: A total of 189,926 patients were included in our study. Compared with 65- to 79-year-old patients, age 80 years or older was associated with 48.4% increased CRC-specific mortality (HR = 1.484, 95% CI = 1.453–1.516, P < 0.0001; using 65–79 years old as the reference). Moreover, not receiving chemotherapy was significantly associated with an increased risk of CRC-related death, independent of other prognostic factors (HR = 0.615, 95% CI = 0.589–0.643, P < 0.0001) in individuals 80 years or older.Conclusions: This large population-based study showed that older age was associated with worse oncologic outcomes compared to younger age. Chemotherapy could offer survival benefit for very old patients diagnosed with CRC, and we strongly believed that very old patients were undertreated in the present medical practices. |
topic |
colorectal cancer chemotherapy 80 years population-based survival |
url |
https://www.frontiersin.org/articles/10.3389/fmed.2020.525421/full |
work_keys_str_mv |
AT wentingliu oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder AT mengyuanzhang oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder AT junwu oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder AT rantang oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder AT liqunhu oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder |
_version_ |
1724676172322701312 |